KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Current Deferred Revenue (2018 - 2025)

LifeMD (LFMD) has disclosed Current Deferred Revenue for 8 consecutive years, with $10.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue fell 36.84% year-over-year to $10.8 million, compared with a TTM value of $10.8 million through Dec 2025, down 36.84%, and an annual FY2025 reading of $10.8 million, down 36.84% over the prior year.
  • Current Deferred Revenue was $10.8 million for Q4 2025 at LifeMD, down from $14.4 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $20.6 million in Q3 2024 and bottomed at $1.3 million in Q1 2021.
  • Average Current Deferred Revenue over 5 years is $8.4 million, with a median of $6.1 million recorded in 2023.
  • The sharpest move saw Current Deferred Revenue soared 355.08% in 2021, then plummeted 36.84% in 2025.
  • Year by year, Current Deferred Revenue stood at $1.5 million in 2021, then soared by 269.86% to $5.5 million in 2022, then soared by 31.08% to $7.3 million in 2023, then soared by 135.16% to $17.1 million in 2024, then tumbled by 36.84% to $10.8 million in 2025.
  • Business Quant data shows Current Deferred Revenue for LFMD at $10.8 million in Q4 2025, $14.4 million in Q3 2025, and $16.9 million in Q2 2025.